Item Type | Name |
Concept
|
Acyclovir
|
Academic Article
|
Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.
|
Academic Article
|
Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.
|
Academic Article
|
Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
|
Academic Article
|
Natural history of neonatal herpes simplex virus infections in the acyclovir era.
|
Academic Article
|
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.
|
Academic Article
|
Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis.
|
Academic Article
|
Effect of recombinant human interferon alpha B/D (rHu-IFN-alpha B/D) in combination with acyclovir in experimental HSV-1 encephalitis.
|
Academic Article
|
Antiviral therapy for neonatal herpes simplex virus: a cost-effectiveness analysis.
|
Academic Article
|
Herpes simplex virus infection.
|
Academic Article
|
Neonatal herpes simplex virus infection.
|
Academic Article
|
HSV shedding.
|
Academic Article
|
Short-course therapy for recurrent genital herpes and herpes labialis.
|
Academic Article
|
Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM.
|
Academic Article
|
Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: a statistical model and its clinical implications. NIAID Collaborative Antiviral Study Group.
|
Academic Article
|
A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group.
|
Academic Article
|
The incidence and severity of herpes simplex encephalitis in Sweden, 1990-2001.
|
Academic Article
|
Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis.
|
Academic Article
|
Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12.
|
Academic Article
|
Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome.
|
Academic Article
|
Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitis.
|
Academic Article
|
Therapy for human herpesvirus infections. A perspective.
|
Academic Article
|
Vidarabine versus acyclovir therapy in herpes simplex encephalitis.
|
Academic Article
|
Yes, brain biopsy should be a prerequisite for herpes simplex encephalitis treatment.
|
Academic Article
|
Interim summary of mortality in herpes simplex encephalitis and neonatal herpes simplex virus infections: vidarabine versus acyclovir.
|
Academic Article
|
Oral acyclovir suppression and neurodevelopment after neonatal herpes.
|
Academic Article
|
Prophylactic or anticipatory antiviral therapy for newborns exposed to herpes simplex infection.
|
Academic Article
|
Therapeutic challenges of neonatal herpes simplex virus infection.
|
Academic Article
|
Treatment of human herpesvirus infections with special reference to encephalitis.
|
Academic Article
|
Herpes simplex encephalitis and clinical trial design.
|
Academic Article
|
Mucocutaneous herpes simplex virus infections in immunocompromised patients. A model for evaluation of topical antiviral agents.
|
Academic Article
|
Towards therapy and prevention of herpetic infections.
|
Academic Article
|
Herpes simplex virus infections of the central nervous system. A review.
|
Academic Article
|
Neonatal herpes simplex virus infections. Presentation and management.
|
Academic Article
|
Neonatal herpes simplex virus infections: pathogenesis and therapy.
|
Academic Article
|
Antiviral treatment of a serious herpes simplex infection: encephalitis.
|
Academic Article
|
Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy.
|
Academic Article
|
Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations.
|
Academic Article
|
Neonatal herpes simplex virus infections: is there a role for immunoglobulin in disease prevention and therapy?
|
Academic Article
|
Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group.
|
Academic Article
|
Neonatal herpes simplex virus infections.
|
Academic Article
|
Acyclovir: a decade later.
|
Academic Article
|
Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group.
|
Academic Article
|
Chickenpox: where do we stand with treatment?
|
Academic Article
|
Natural history and treatment of varicella-zoster in high-risk populations.
|
Academic Article
|
Acyclovir: the past ten years.
|
Academic Article
|
Therapeutic approaches to varicella-zoster virus infections.
|
Academic Article
|
Acyclovir kinetics after intravenous infusion.
|
Academic Article
|
Ganciclovir--have we established clinical value in the treatment of cytomegalovirus infections?
|
Academic Article
|
Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group.
|
Academic Article
|
Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial.
|
Academic Article
|
Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers.
|
Academic Article
|
A controlled trial of acyclovir for chickenpox in normal children.
|
Academic Article
|
Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications.
|
Academic Article
|
Antiviral therapy: the time has come.
|
Academic Article
|
Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals.
|
Academic Article
|
Herpes zoster in patients with human immunodeficiency virus infection--an ever-expanding spectrum of disease.
|
Academic Article
|
The past as prelude to the future: history, status, and future of antiviral drugs.
|
Academic Article
|
Therapeutic approaches to the management of herpes zoster.
|
Academic Article
|
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
|
Academic Article
|
Herpes zoster: risk categories for persistent pain.
|
Academic Article
|
Approaches to the treatment of varicella-zoster virus infections.
|
Academic Article
|
New therapeutic approaches to the alphaherpesvirus infections.
|
Academic Article
|
Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials.
|
Academic Article
|
Advances in the management of herpesvirus infections. Introduction.
|
Academic Article
|
HSV-2 transmission.
|
Academic Article
|
Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.
|
Academic Article
|
Recommendations for the management of herpes zoster.
|
Academic Article
|
Neonatal herpes: what have we learned.
|
Academic Article
|
The use of antiviral drugs during the neonatal period.
|
Academic Article
|
Recurrent benign lymphocytic meningitis.
|
Academic Article
|
Current management and recommendations for access to antiviral therapy of herpes labialis.
|
Academic Article
|
Varicella-zoster virus infections: chronic disease in the immunocompromised host: evidence for persistent excretion of virus.
|
Academic Article
|
Therapeutic approaches to the control of cytomegalovirus infections.
|
Academic Article
|
Unique clinical trial design: combination acyclovir plus prednisone therapy of localized zoster in the normal host.
|
Academic Article
|
Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy.
|